Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
SANA | US
-0.13
-2.98%
Healthcare
Biotechnology
30/06/2024
04/10/2024
4.23
4.36
4.40
4.22
Sana Biotechnology Inc. a biotechnology company focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs including oncology diabetes central nervous system disorders cardiovascular diseases genetic disorders and others. Its product candidates include SG299 and SG242 that targets CD19+ cancer cells in patients with non-Hodgkin Lymphoma (NHL) chronic lymphocytic leukemia (CLL) and acute lymphoblastic leukemia (ALL); SG221 and SG239 for the treatment of multiple myeloma; and SG233 a CD22 CAR for the treatment of NHL CLL and ALL. It also develops SG418 for sickle cell disease and beta-thalassemia; SC291 a CD19 allogeneic T cell therapy; SC255 a B cell maturation antigen directed allogeneic CAR T for multiple myeloma; SC45 the PSC-derived pancreatic islet cells for type I diabetes mellitus; and SC379 for secondary progressive multiple sclerosis Pelizaeus-Merzbacher disease Huntington's disease and other astrocytic diseases. The company was formerly known as FD Therapeutics Inc. and changed its name to Sana Biotechnology Inc. in September 2018. The company was incorporated in 2018 and is based in Seattle Washington.
View LessLow Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Negative Momentum (Declining Price)
High Short-term Volatility
High 6-Month Volatility (>65%)
Smallcap (300M - 2B USD)
High Market Beta (> 0.8)
High Short percentage (> 15%)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
99.1%1 month
80.0%3 months
77.4%6 months
79.0%-
-
2.80
0.29
0.16
-1.08
-
-
-272.59M
941.03M
941.03M
-
-
-
-
-70.51
22.79
29.07
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
0.95
Range1M
2.10
Range3M
3.72
Rel. volume
0.50
Price X volume
3.36M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
AnaptysBio Inc | ANAB | Biotechnology | 33.98 | 1.03B | -2.91% | n/a | 3835.68% |
Aurinia Pharmaceuticals Inc | AUPH | Biotechnology | 7.12 | 1.02B | 0.00% | n/a | 23.58% |
Pharvaris B.V | PHVS | Biotechnology | 18.2 | 982.94M | -0.66% | n/a | 0.04% |
Array BioPharma Inc | ARRY | Biotechnology | 6.45 | 979.92M | 0.62% | 67.30 | 117.68% |
Silence Therapeutics plc | SLN | Biotechnology | 18.64 | 933.49M | 1.30% | n/a | 0.16% |
Prothena Corporation plc | PRTA | Biotechnology | 16.86 | 906.74M | 1.08% | n/a | 2.08% |
Zymeworks Inc | ZYME | Biotechnology | 12.57 | 893.07M | 1.45% | n/a | 4.94% |
Applied Therapeutics Inc | APLT | Biotechnology | 7.7 | 884.31M | -8.22% | n/a | 0.30% |
Cronos Group Inc | CRON | Biotechnology | 2.24 | 856.31M | 3.70% | n/a | 0.19% |
iShares $ Corp Bond ETF USD Dist | LQDA | Biotechnology | 10.03 | 846.31M | 0.25% | n/a | 4.70% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Malibu Boats Inc | MBUU | Recreational Vehicles | 39.7 | 793.63M | -0.68% | n/a | 1.50% |
Latham Group Inc. | SWIM | Building Products & Equipment | 6.64 | 767.43M | 0.00% | 61.27 | 77.00% |
Ennis Inc | EBF | Building Products & Equipment | 24.31 | 631.67M | 2.36% | 15.15 | 2.42% |
ACCO Brands Corporation | ACCO | Building Products & Equipment | 5.25 | 502.94M | -0.19% | n/a | 174.23% |
Lincoln Educational Services Corporation | LINC | Building Products & Equipment | 11.63 | 366.05M | 0.00% | 47.92 | 88.92% |
ONEWATER MARINE INC. | ONEW | Recreational Vehicles | 21.28 | 334.47M | -4.23% | n/a | 286.96% |
Marine Products Corporation | MPX | Recreational Vehicles | 9.47 | 328.78M | 0.21% | 13.24 | 0.00% |
MCBC Holdings Inc | MCFT | Recreational Vehicles | 17.64 | 292.95M | -0.56% | 35.53 | 26.82% |
CPI Card Group Inc | PMTS | Building Products & Equipment | 23.62 | 261.38M | 4.61% | 17.90 | -621.78% |
Virco Mfg. Corporation | VIRC | Building Products & Equipment | 13.5 | 219.91M | 1.89% | 8.52 | 39.79% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -1.08 | 0.76 | Cheaper |
Ent. to Revenue | - | 3,674.48 | - |
PE Ratio | - | 38.01 | - |
Price to Book | 2.80 | 14.10 | Cheaper |
Dividend Yield | - | 2.22 | - |
Std. Deviation (3M) | 77.43 | 74.67 | Par |
Debt to Equity | 0.29 | -1.82 | Expensive |
Debt to Assets | 0.16 | 0.26 | Cheaper |
Market Cap | 941.03M | 3.73B | Emerging |